Related Experiment Videos
Pediatric liver transplantation: Part II. Managing the long-term complications
Insights
Pediatric liver transplant recipients require careful long-term follow-up. This review covers complications, cyclosporine management, infections, and acute rejection in children after liver transplantation.
Area of Science:
- Pediatric Gastroenterology
- Transplant Hepatology
- Immunology
Background:
- Liver transplantation in children is increasing, with many returning to local hospitals for care.
- Long-term management of pediatric liver transplant recipients presents unique challenges.
- Effective communication between transplant centers and home hospitals is crucial.
Purpose of the Study:
- To review long-term complications in pediatric liver transplant recipients.
- To provide guidance on recognition and management of these complications.
- To enhance understanding of immunosuppressive drug pharmacokinetics and toxicity.
Main Methods:
- Literature review focusing on pediatric liver transplant outcomes.
- Analysis of common infectious diseases and their presentations in immunocompromised children.
- Summary of therapeutic strategies for acute rejection episodes.
Main Results:
- Long-term complications require vigilant monitoring and management.
- Cyclosporine pharmacokinetics and toxicity are key considerations.
- Viral infections are common and present distinct clinical features in this population.
Conclusions:
- Optimizing long-term care for pediatric liver transplant recipients involves understanding potential complications and infections.
- Familiarity with immunosuppression, particularly cyclosporine, and rejection management is essential for home healthcare providers.
- Improved communication and knowledge sharing can enhance patient outcomes.
Abstract:
Increasing numbers of children are receiving liver transplants at major centers and returning to their home hospitals for long-term follow-up. This review summarizes the long-term complications in pediatric liver transplant recipients and their recognition and management. Emphasis is placed on an understanding of the practical aspects of the pharmacokinetics and toxicity of cyclosporine, the major immunosuppressive drug used in these patients. Common infectious problems, particularly serious viral infections, are reviewed with their unique clinical presentations in this immunocompromised population. Therapeutic alternatives for episodes of acute rejection are offered to facilitate communication with the transplant center and familiarize the local pediatric gastroenterologist and his or her staff with the management issues facing those who take care of these complex patients.